Dendrimer nanoplatforms for oral drug delivery applications

被引:1
作者
Kim, Dohyun [1 ]
Kim, Sungjun [2 ]
Na, Dong Hee [1 ,2 ]
机构
[1] Chung Ang Univ, Coll Pharm, 84 Heukseok Ro, Seoul 06974, South Korea
[2] Chung Ang Univ, Grad Sch, Dept Global Innovat Drugs, Seoul 06974, South Korea
基金
新加坡国家研究基金会;
关键词
Dendrimer; Oral drug delivery; Permeability; Pharmacokinetics; Bioavailability; Polyamidoamine; POLYAMIDOAMINE PAMAM DENDRIMERS; POLY AMIDOAMINE DENDRIMERS; TRANSEPITHELIAL TRANSPORT; IN-VITRO; POLY(AMIDOAMINE) DENDRIMERS; ABSORPTION ENHANCERS; SURFACE MODIFICATION; BIOAVAILABILITY; PERMEABILITY; NANOPARTICLES;
D O I
10.1007/s40005-024-00716-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BackgroundDendrimers are highly branched tree-like nanostructures with inner cavities and surface versatility. Notably, multiple studies point to their potential in oral drug delivery, yet not much attention has been given compared to other nanocarriers.Area coveredThis review provides an overview of dendrimer applications for oral drug delivery, highlighting important findings from previous and up-to-date research. We also discuss the essential aspects for understanding and further designing dendrimer-based formulations, including their unique properties, proposed mechanisms, surface engineering, biocompatibility, and biodistribution, all specifically in the context of oral applications. Our goal is to offer readers new insights into this topic and facilitate further exploration of these promising applications.Expert opinionDendrimers have demonstrated high potential for oral drug delivery. However, to maximize their utility in this field, they should clearly outperform other competitive nanocarriers in effectiveness and industrial viability. The unique properties of dendrimers, successfully utilized in various biomedical applications, need to be fully leveraged in oral drug delivery, with an additional focus on targeting indications relevant to oral use. We anticipate that future studies will present a strong opportunity to capitalize on the distinctive advantages of dendrimers in oral drug delivery applications.
引用
收藏
页码:169 / 189
页数:21
相关论文
共 113 条
[71]   MICELLES .1. CASCADE MOLECULES - A NEW APPROACH TO MICELLES - A [27]-ARBOROL [J].
NEWKOME, GR ;
YAO, ZQ ;
BAKER, GR ;
GUPTA, VK .
JOURNAL OF ORGANIC CHEMISTRY, 1985, 50 (11) :2003-2004
[73]   All-atomistic molecular dynamics (AA-MD) studies and pharmacokinetic performance of PAMAM-dendrimer-furosemide delivery systems [J].
Otto, Daniel P. ;
de Villiers, Melgardt M. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 547 (1-2) :545-555
[74]   Emerging PEGylated non-biologic drugs [J].
Park, Eun Ji ;
Choi, Jiyoung ;
Lee, Kang Choon ;
Na, Dong Hee .
EXPERT OPINION ON EMERGING DRUGS, 2019, 24 (02) :107-119
[75]   Difference in microchip electrophoretic mobility between partially and fully PEGylated poly(amidoamine) dendrimers [J].
Park, Eun Ji ;
Na, Dong Hee .
ANALYTICAL BIOCHEMISTRY, 2015, 488 :9-11
[76]   Chromatographic methods for characterization of poly(ethylene glycol)-modified polyamidoamine dendrimers [J].
Park, Eun Ji ;
Cho, Hoon ;
Kim, Si Wouk ;
Na, Dong Hee .
ANALYTICAL BIOCHEMISTRY, 2014, 449 :42-44
[77]   PEGylated nanoparticle albumin-bound steroidal ginsenoside derivatives ameliorate SARS-CoV-2-mediated hyper-inflammatory responses [J].
Park, Hee Ho ;
Kim, Hyelim ;
Lee, Han Sol ;
Seo, Eun U. ;
Kim, Ji-Eun ;
Lee, Jee-Hyun ;
Mun, Yong-Hyeon ;
Yoo, So-Yeol ;
An, Jiseon ;
Yun, Mi-Young ;
Kang, Nae-Won ;
Kim, Dae-Duk ;
Na, Dong Hee ;
Hong, Kyung Soo ;
Jang, Jong Geol ;
Ahn, June Hong ;
Bae, Jong-Sup ;
Song, Gyu Yong ;
Lee, Jae-Young ;
Kim, Hong Nam ;
Lee, Wonhwa .
BIOMATERIALS, 2021, 273
[78]  
Patel D., 2021, Applications of polymers in drug delivery, P159, DOI [10.1016/B978-0-12-819659-5.00006-9, DOI 10.1016/B978-0-12-819659-5.00006-9]
[79]   Permeability of surface-modified polyamidoamine (PAMAM) dendrimers across Caco-2 cell monolayers [J].
Pisal, Dipak S. ;
Yellepeddi, Venkata K. ;
Kumar, Ajay ;
Kaushik, Radhey S. ;
Hildreth, Michael B. ;
Guan, Xiangming ;
Palakurthi, Srinath .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 350 (1-2) :113-121
[80]  
Porterfield JE, 2023, BIOENG TRANSL MED, V8, DOI 10.1002/btm2.10486